143 related articles for article (PubMed ID: 34637340)
21. Notch3 overexpression associates with poor prognosis in human non-small-cell lung cancer.
Ye YZ; Zhang ZH; Fan XY; Xu XL; Chen ML; Chang BW; Zhang YB
Med Oncol; 2013; 30(2):595. PubMed ID: 23645556
[TBL] [Abstract][Full Text] [Related]
22. Increased stathmin correlates with advanced stage and poor survival of non-small cell lung cancer.
Rong B; Nan Y; Liu H; Gao W
Cancer Biomark; 2017; 19(1):35-43. PubMed ID: 28282798
[TBL] [Abstract][Full Text] [Related]
23. Association between BMP4 expression and pathology, CT characteristics and prognosis of non-small cell lung cancer.
Ju FJ; Meng FQ; Hu HL; Liu J
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5787-5794. PubMed ID: 31298330
[TBL] [Abstract][Full Text] [Related]
24. Overexpression and cytoplasmic accumulation of Hepl is associated with clinicopathological parameters and poor prognosis in non-small cell lung cancer.
Miao Y; Wang L; Liu Y; Li AL; Liu SL; Cao HY; Zhang XP; Jiang GY; Liu D; Wang EH
Tumour Biol; 2013 Feb; 34(1):107-14. PubMed ID: 23001926
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of NEDD9 is associated with altered expression of E-Cadherin, β-Catenin and N-Cadherin and predictive of poor prognosis in non-small cell lung cancer.
Miao Y; Li AL; Wang L; Fan CF; Zhang XP; Xu HT; Yang LH; Liu Y; Wang EH
Pathol Oncol Res; 2013 Apr; 19(2):281-6. PubMed ID: 23086683
[TBL] [Abstract][Full Text] [Related]
26. Circular RNA ciRS-7 correlates with advance disease and poor prognosis, and its down-regulation inhibits cells proliferation while induces cells apoptosis in non-small cell lung cancer.
Yan B; Zhang W; Mao XW; Jiang LY
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8712-8721. PubMed ID: 30575911
[TBL] [Abstract][Full Text] [Related]
27. Elevated expression of SHIP2 correlates with poor prognosis in non-small cell lung cancer.
Fu M; Fan W; Pu X; Ni H; Zhang W; Chang F; Gong L; Xiong L; Wang J; Gu X
Int J Clin Exp Pathol; 2013; 6(10):2185-91. PubMed ID: 24133597
[TBL] [Abstract][Full Text] [Related]
28. MiRNA-30 Play an Important Role in Non-Small Cell Lung Cancer (NSCLC).
Sui JYAX
Clin Lab; 2020 Apr; 66(4):. PubMed ID: 32255283
[TBL] [Abstract][Full Text] [Related]
29. Detection of Occult Micrometastases in Patients With Clinical Stage I Non-Small-Cell Lung Cancer: A Prospective Analysis of Mature Results of CALGB 9761 (Alliance).
Martin LW; D'Cunha J; Wang X; Herzan D; Gu L; Abraham N; Demmy TL; Detterbeck FC; Groth SS; Harpole DH; Krasna MJ; Kernstine K; Kohman LJ; Patterson GA; Sugarbaker DJ; Vollmer RT; Maddaus MA; Kratzke RA
J Clin Oncol; 2016 May; 34(13):1484-91. PubMed ID: 26926677
[TBL] [Abstract][Full Text] [Related]
30. Circular RNA_0001946 is insufficiently expressed in tumor tissues, while its higher expression correlates with less lymph node metastasis, lower TNM stage, and improved prognosis in NSCLC patients.
Zhang M; Wen F; Zhao K
J Clin Lab Anal; 2021 Aug; 35(8):e23625. PubMed ID: 34216509
[TBL] [Abstract][Full Text] [Related]
31. The expression of p33(ING1), p53, and autophagy-related gene Beclin1 in patients with non-small cell lung cancer.
Liu J; Lin Y; Yang H; Deng Q; Chen G; He J
Tumour Biol; 2011 Dec; 32(6):1113-21. PubMed ID: 21779982
[TBL] [Abstract][Full Text] [Related]
32. PBK/TOPK expression in non-small-cell lung cancer: its correlation and prognostic significance with Ki67 and p53 expression.
Lei B; Liu S; Qi W; Zhao Y; Li Y; Lin N; Xu X; Zhi C; Mei J; Yan Z; Wan L; Shen H
Histopathology; 2013 Nov; 63(5):696-703. PubMed ID: 24025073
[TBL] [Abstract][Full Text] [Related]
33. [Prognostic value of MACC1 and c-met expressions in non-small cell lung cancer].
Hu X; Fu X; Wen S; Zou X; Liu Y
Zhongguo Fei Ai Za Zhi; 2012 Jul; 15(7):399-403. PubMed ID: 22814258
[TBL] [Abstract][Full Text] [Related]
34. Cyclin-Dependent Kinase 14 Promotes Cell Proliferation, Migration and Invasion in Ovarian Cancer by Inhibiting Wnt Signaling Pathway.
Ou-Yang J; Huang LH; Sun XX
Gynecol Obstet Invest; 2017; 82(3):230-239. PubMed ID: 27505004
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of PP2A inhibitor SET oncoprotein is associated with tumor progression and poor prognosis in human non-small cell lung cancer.
Liu H; Gu Y; Wang H; Yin J; Zheng G; Zhang Z; Lu M; Wang C; He Z
Oncotarget; 2015 Jun; 6(17):14913-25. PubMed ID: 25945834
[TBL] [Abstract][Full Text] [Related]
36. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
[TBL] [Abstract][Full Text] [Related]
37. [Expressions and significances of CRABPII and E-FABP in non-small cell lung cancer].
Liu Q; Wang S; Xu H; Zhang S
Zhongguo Fei Ai Za Zhi; 2013 Jan; 16(1):12-9. PubMed ID: 23327868
[TBL] [Abstract][Full Text] [Related]
38. [Expression of TRIM59 in Non-small Cell Lung Cancer and Its Correlation with Prognosis].
Tian H; Zhang D; Xu R; Qin Y; Lan Y; Jiao W; Han Y
Zhongguo Fei Ai Za Zhi; 2020 Jan; 23(1):21-28. PubMed ID: 31948534
[TBL] [Abstract][Full Text] [Related]
39. Dysregulated transient receptor potential channel 1 expression and its correlation with clinical features and survival profile in surgical non-small-cell lung cancer patients.
Ke C; Long S
J Clin Lab Anal; 2022 Mar; 36(3):e24229. PubMed ID: 35106847
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of P21-activated kinase 4 is associated with poor prognosis in non-small cell lung cancer and promotes migration and invasion.
Cai S; Ye Z; Wang X; Pan Y; Weng Y; Lao S; Wei H; Li L
J Exp Clin Cancer Res; 2015 May; 34(1):48. PubMed ID: 25975262
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
